Uncategorized

Walgreens’ second-quarter report is one of its last financial disclosures before the struggling drugstore chain ends its century-long run as a public company.

The decision is a setback for GLP-1 drugmakers, though it’s not entirely surprising given the Trump administration’s focus on curbing government spending.

Amid the whirlwind of tariff news, AdvaMed and other healthcare groups have pleaded for the Trump administration to exempt medical devices and critical supplies.

Tom Cowhey, who took on the permanent CFO position at CVS early last year, will serve as a strategic advisor to CEO David Joyner.

The 5.1% benchmark increase is the largest in the past decade, a hike that reflects more recent data capturing cost growth, according to the CMS. Though, the Trump administration likely “had its finger on the scale,” one analyst said.

Long considered resistant to economic downturns, the pharmaceutical industry may face a greater challenge this time around as GLP-1s dominate and the population grows older.

Last week, The Trump administration reversed a Biden-era proposal for Medicare coverage of anti-obesity treatments. But on Monday, HHS suggested it is open to future policy considerations toward this end.

HELP committee chair Bill Cassidy, R-La., had invited Kennedy to testify April 10 on the sweeping layoffs of federal health workers Kennedy ordered last month. A hearing could still take place later. 

Merida is working on a selective therapy for Graves’ disease, leveraging targeted therapies that can deplete disease-causing autoantibodies.

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it emits waves from its tip.